Psychedelic Medicine PAC seeks to elect leaders who support pro-psilocybin reforms

The Political Action Committee (PAC), created to defend the use of psychedelic drugs in the country, aims to elect a leader who will support pro-psilocybin reform.

NBC News report Monday that the newly created Psychedelic Medicine PAC wants to elect a leader to support the therapeutic use of psychedelic substances such as psilocybin, ketamine and MDMA (ecstasy).

Ryan Rodgers, executive director and co-founder of the Psychedelic Medicine PAC, told NBC News that the group is in the early stages of fundraising and is open to donors of all levels interested in funding the PAC. I pointed out that I was reaching out.

The PAC also wants to secure federal funding to increase education and research into the use of psychedelic drugs, and is also aiming to raise $10 million in its first year, according to NBC News.

“You have to convince the historically diehard audience of psychedelics that this is not the 1960s,” Rogers said.

“People don’t stare into the sun to close their eyes. People don’t jump off buildings,” he said. “This is trauma healing. It’s not entertainment.”

Proponents promote the therapeutic use of psychedelics, claiming they are safer and more effective than prescription drugs, and several recent clinical studies back up proponents’ claims.

Recently, the Biden administration has explored the possibility of launching a task force focused on psychedelic research and research in hopes that the Food and Drug Administration will approve the drug’s therapeutic use in the future, NBC said. The news reported

Earlier this month, Rep. Lou Correa (D-California) and Rep. Jack Bergman (R-Michigan) resumed The Congressional Psychedelic Advancing Therapy (PATH) Caucus as an avenue to “address ways to alleviate the national mental health crisis through psychedelic science and research.”

The group also said it wanted to secure support from both Republicans and Democrats, NBC News noted.

“We want to ensure that what we are advocating does not provoke opposition to this issue within the halls of Congress,” said Melissa Lavasani, co-founder and executive director of the Psychedelic Medicine PAC. We have seen that some of the strategies employed by the movement have been really divisive and that have really slowed some of the progress.